Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03331445
Recruitment Status : Terminated (Covid Incidence too low and Funding Completed)
First Posted : November 6, 2017
Last Update Posted : July 16, 2021
Sponsor:
Collaborator:
Mallinckrodt
Information provided by (Responsible Party):
Chris Miller, Nitric Solutions Inc.